AR112695A1 - Inhibidores de cdpk1, composiciones y métodos relacionados con los mismos - Google Patents

Inhibidores de cdpk1, composiciones y métodos relacionados con los mismos

Info

Publication number
AR112695A1
AR112695A1 ARP180102364A AR112695A1 AR 112695 A1 AR112695 A1 AR 112695A1 AR P180102364 A ARP180102364 A AR P180102364A AR 112695 A1 AR112695 A1 AR 112695A1
Authority
AR
Argentina
Prior art keywords
cdpk1
inhibitors
compositions
related methods
cycloalkyl
Prior art date
Application number
Other languages
English (en)
Original Assignee
Vyera Pharmaceuticals Llc
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vyera Pharmaceuticals Llc, Univ Washington filed Critical Vyera Pharmaceuticals Llc
Publication of AR112695A1 publication Critical patent/AR112695A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto con la estructura de fórmula (1) o una sal aceptable farmacéutico del mismo, en la que: X es R⁶, O, S, (NR⁴), OR⁶, SR⁶, o (NR⁴)R⁶; Y es N o CH; R¹ es arilo C₆₋₁₀ o heteroarilo de 5 - 10 miembros; R² es cicloalquilo C₃₋₆; R³ es H, alquilo C₁₋₆, haloalquilo C₁₋₆, o cicloalquilo C₃₋₆; R⁴ es H o alquilo C₁₋₆; y R⁶ es alquileno C₁₋₆ o alquenileno C₁₋₆.
ARP180102364 2017-08-17 2018-08-17 Inhibidores de cdpk1, composiciones y métodos relacionados con los mismos AR112695A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762546921P 2017-08-17 2017-08-17

Publications (1)

Publication Number Publication Date
AR112695A1 true AR112695A1 (es) 2019-11-27

Family

ID=65362407

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180102364 AR112695A1 (es) 2017-08-17 2018-08-17 Inhibidores de cdpk1, composiciones y métodos relacionados con los mismos

Country Status (5)

Country Link
US (1) US11518761B2 (es)
EP (1) EP3668875A4 (es)
AR (1) AR112695A1 (es)
TW (1) TW201920184A (es)
WO (1) WO2019036001A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019036001A1 (en) 2017-08-17 2019-02-21 Vyera Pharmaceuticals, LLC CDPK1 INHIBITOR, COMPOSITIONS AND RELATED METHODS
MA53672A (fr) * 2018-09-19 2021-07-28 Vyera Pharmaceuticals Llc Inhibiteurs de cdpk1, compositions et procédés associés

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593997A (en) 1995-05-23 1997-01-14 Pfizer Inc. 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
UA80171C2 (en) 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
JP2008520744A (ja) * 2004-11-19 2008-06-19 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 抗炎症性ピラゾロピリミジン
JP2011503103A (ja) 2007-11-07 2011-01-27 フォールドアールエックス ファーマシューティカルズ インコーポレーティッド タンパク質輸送の調節方法
EP2358720B1 (en) * 2008-10-16 2016-03-02 The Regents of The University of California Fused ring heteroaryl kinase inhibitors
US9765037B2 (en) 2010-01-28 2017-09-19 University Of Washington Through Its Center For Commercialization Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases
WO2011153553A2 (en) 2010-06-04 2011-12-08 The Regents Of The University Of California Methods and compositions for kinase inhibition
US8642606B2 (en) * 2010-09-29 2014-02-04 Plexxikon Inc. ZAP-70 active compounds
WO2013010136A2 (en) * 2011-07-13 2013-01-17 Pharmacyclics, Inc. Inhibitors of bruton's tyrosine kinase
US11208411B2 (en) * 2016-03-17 2021-12-28 The Regents Of The University Of California Compositions and methods for treating parasitic diseases
TW201837040A (zh) 2017-03-15 2018-10-16 美商微拉製藥公司 Cdpk1抑制劑及與其相關之組合物及方法
WO2019036001A1 (en) 2017-08-17 2019-02-21 Vyera Pharmaceuticals, LLC CDPK1 INHIBITOR, COMPOSITIONS AND RELATED METHODS
MA53672A (fr) 2018-09-19 2021-07-28 Vyera Pharmaceuticals Llc Inhibiteurs de cdpk1, compositions et procédés associés

Also Published As

Publication number Publication date
TW201920184A (zh) 2019-06-01
EP3668875A4 (en) 2020-12-30
WO2019036001A1 (en) 2019-02-21
US11518761B2 (en) 2022-12-06
EP3668875A1 (en) 2020-06-24
US20210032240A1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
AR109349A1 (es) Compuestos y usos
AR107519A1 (es) Compuestos de piperidina sustituido y su uso
AR114793A1 (es) Moduladores de enzimas modificadoras de metilo, composiciones y usos de los mismos
AR103138A1 (es) Compuestos de heteroarilo como inhibidores de la irak y usos de los mismos
AR111407A1 (es) Compuestos inhibidores de ask1 y usos de los mismos
AR100809A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
AR100033A1 (es) Compuestos y composiciones para inhibir la actividad de shp2
AR094537A1 (es) COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa
AR100808A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
AR107428A1 (es) COMPUESTOS DE ISOXAZOL DE ÁCIDO HIDROXÁMICO COMO INHIBIDORES DE LpxC
AR101815A1 (es) Compuestos y composiciones como inhibidores de quinasa
AR116283A1 (es) Inhibidores del sarcómero cardíaco
AR094812A1 (es) Derivado de piridina monocíclico como inhibidor del fgfr
AR090474A1 (es) Compuestos de tetrahidropirrolotiazina
AR097082A1 (es) Compuestos terapéuticamente activos y sus métodos de uso
AR118724A1 (es) Inhibidores de dihidroorotato deshidrogenasa
AR111282A1 (es) Inhibidores de cdpk1 ii, composiciones y métodos relacionados con los mismos
AR104880A1 (es) MODULADORES DE ROR GAMMA (RORg)
AR116114A1 (es) Amidas heterocíclicas de entre 5 y 7 miembros como inhibidores de jak
AR106604A1 (es) Compuestos de criptoficina y productos conjugados, su preparación y su uso terapéutico
AR107955A1 (es) Derivados de piridino- / pirimidino-piridina, con actividad herbicida
AR089814A1 (es) Compuestos que modulan la actividad de los proteasomas
AR094797A1 (es) Derivados de pirrolotriazina como inhibidores de pi3k
AR098723A1 (es) Derivados de pirazolopirimidin-2-ilo como inhibidores de jak
AR112695A1 (es) Inhibidores de cdpk1, composiciones y métodos relacionados con los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure